Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Neovasc Inc.

www.neovasc.com

Latest From Epirus Switzerland GMBH

R&D In Brief: Imaging Agent Approvals, EULAR Updates, Post-ASCO Cancer Data

FDA approves new oncology imaging agents and a long-acting hemophilia drug; Sanofi/Regeneron present positive Phase III on RA drug sarilumab; biosimilar infliximab shows no meaningful differences to Remicade; Imbruvica response rates improved with umblituximab; Cyramza fails survival endpoint in liver cancer.

BioPharmaceutical North America

Deals Shaping The Medical Industry, February 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced December 2013 through January 2014.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Medical Ventures Corp.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Neovasc Inc.
  • Senior Management
  • Alexei Marko, CEO & Dir.
    Christopher Clark, CFO
    Shmuel Banai, MD, Medical Dir.
    Brian McPherson, COO
    Randy Lane, VP, R&D
  • Contact Info
  • Neovasc Inc.
    Phone: (604) 270-4344
    13562 Maycrest Way, #5138
    Richmond, V6V 2J7
    Canada
Advertisement
Advertisement
UsernamePublicRestriction

Register